Waqar Ahmad1, Imran Khan1, Mir Azam Khan1, Manzoor Ahmad2, Fazal Subhan3, Nasiara Karim4. 1. Department of Pharmacy, University of Malakand, Chakdara, Pakistan. 2. Department of Chemistry, University of Malakand, Chakdara, Pakistan. 3. Department of Pharmacy, University of Peshawar, Peshawar, Pakistan. 4. Department of Pharmacy, University of Malakand, Chakdara, Pakistan. Electronic address: nasiara.karim@hotmail.com.
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Diabetes mellitus is a major metabolic disorder affecting a huge population all over the world. Artemisia species have been extensively used for the management of diabetes in folkloric medicine. The present study is designed to investigate the antidiabetic and antihyperlipidemic effects of aeriel parts of Artemisia indica. MATERIALS AND METHODS: Hydromethanolic crude extracts, chloroform, ethyl acetate and n-butanol fractions of aerial parts of Artemisia indica were tested for their antidiabetic potential in Streptozotocin (STZ) (50mg/kg, i.p.) induced diabetic Sprague-Dawley rats. Blood glucose level, body weight, serum lipid profile and activities of liver enzymes were determined. The extracts were further subjected to preliminary phytochemical analysis. RESULTS: A daily oral dose of hydromethanolic crude extracts (200 and 400mg/kg b.w.) and chloroform fraction (200mg/kg b.w.) of Artemisia indica for 15 days showed a significant reduction in blood glucose level which was comparable to that of the standard antidiabetic drug, glibenclamide (500 μg/kg, p.o.). Artemisia indica extracts also showed reduction in total cholesterol, triglycerides and low density lipoproteins as well as serum creatinine level, serum glutamate pyruvate transaminase (SGPT), serum glutamate oxaloacetate transaminase (SGOT) and alkaline phosphatase (ALP) in diabetic rats. CONCLUSION: According to the results Artemisia indica possesses hypoglycemic, antihyperlipidemic and valuable effects on liver and renal functions in diabetic rats, which seems to validate its traditional usage.
ETHNOPHARMACOLOGICAL RELEVANCE: Diabetes mellitus is a major metabolic disorder affecting a huge population all over the world. Artemisia species have been extensively used for the management of diabetes in folkloric medicine. The present study is designed to investigate the antidiabetic and antihyperlipidemic effects of aeriel parts of Artemisia indica. MATERIALS AND METHODS:Hydromethanolic crude extracts, chloroform, ethyl acetate and n-butanol fractions of aerial parts of Artemisia indica were tested for their antidiabetic potential in Streptozotocin (STZ) (50mg/kg, i.p.) induced diabeticSprague-Dawley rats. Blood glucose level, body weight, serum lipid profile and activities of liver enzymes were determined. The extracts were further subjected to preliminary phytochemical analysis. RESULTS: A daily oral dose of hydromethanolic crude extracts (200 and 400mg/kg b.w.) and chloroform fraction (200mg/kg b.w.) of Artemisia indica for 15 days showed a significant reduction in blood glucose level which was comparable to that of the standard antidiabetic drug, glibenclamide (500 μg/kg, p.o.). Artemisia indica extracts also showed reduction in total cholesterol, triglycerides and low density lipoproteins as well as serum creatinine level, serum glutamate pyruvate transaminase (SGPT), serum glutamate oxaloacetate transaminase (SGOT) and alkaline phosphatase (ALP) in diabeticrats. CONCLUSION: According to the results Artemisia indica possesses hypoglycemic, antihyperlipidemic and valuable effects on liver and renal functions in diabeticrats, which seems to validate its traditional usage.
Authors: Jin Li; Tamara Casteels; Thomas Frogne; Camilla Ingvorsen; Christian Honoré; Monica Courtney; Kilian V M Huber; Nicole Schmitner; Robin A Kimmel; Roman A Romanov; Caterina Sturtzel; Charles-Hugues Lardeau; Johanna Klughammer; Matthias Farlik; Sara Sdelci; Andhira Vieira; Fabio Avolio; François Briand; Igor Baburin; Peter Májek; Florian M Pauler; Thomas Penz; Alexey Stukalov; Manuela Gridling; Katja Parapatics; Charlotte Barbieux; Ekaterine Berishvili; Andreas Spittler; Jacques Colinge; Keiryn L Bennett; Steffen Hering; Thierry Sulpice; Christoph Bock; Martin Distel; Tibor Harkany; Dirk Meyer; Giulio Superti-Furga; Patrick Collombat; Jacob Hecksher-Sørensen; Stefan Kubicek Journal: Cell Date: 2016-12-01 Impact factor: 41.582
Authors: Khalid Ghazanfar; Bashir A Ganai; Seema Akbar; Khan Mubashir; Showkat Ahmad Dar; Mohammad Younis Dar; Mudasir A Tantry Journal: Biomed Res Int Date: 2014-05-21 Impact factor: 3.411